在间歇性肺病中,急性恶化和渐进性肺纤维化之间的关联:一项回顾性队列研究
Liying Zhai1, Zhiqiang Wang2, Wencheng Yu3
1Department of Pulmonary and Critical Care Medicine, the affiliated hospital of Qingdao University, Qingdao, China.
Therapeutic advances in respiratory disease
|September 5, 2024
概括
在间歇性肺病 (ILD) 患者中,急性恶化 (AE) 在出现渐进性肺纤维化 (PPF) 时不会增加死亡风险. 然而,无论AE状态如何,PPF始终会使ILD患者的预后恶化.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 间歇性肺病 (ILD) 涵盖了以渐进性肺纤维化 (PPF) 为特征的疾病.
- 急性恶化 (AE) 代表了ILD内的呼吸功能快速恶化.
- 在ILD预后中AE和PPF之间的相互作用仍未得到充分研究.
研究的目的:
- 在被诊断患有ILD的患者中调查AE和PPF之间的关联.
- 为了确定AE是否影响ILD患者的死亡风险,考虑到PPF的存在或不存在.
主要方法:
- 一项回顾性队列研究,涉及414名住院的ILD患者.
- 对临床表现,放射特征和实验室发现的分析.
- 基于PPF存在的分层分析来评估AE对死亡率的影响.
主要成果:
- 副作用发生在29.0%的ILD患者中,最初与死亡率增加有关.
- 当患者根据PPF状态分层时,AE和死亡率之间的这种关联消失了.
- 在AE和非AEILD患者中,PPF始终显示出对预后的不利影响.
结论:
- 虽然AE和PPF都与ILD的预后不佳有关,但PPF对死亡率的影响与AE无关.
- 当考虑PPF时,AE对预后的有害影响会减轻.
- 专注于预防AE后的疾病进展和PPF早期抗纤维素治疗至关重要.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:21Acute Respiratory Failure-II
186
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
186
01:20COPD: Pathogenesis and Clinical Features
244
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
244
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K